HEADER OXIDOREDUCTASE 11-MAR-22 7Z6C TITLE CRYSTAL STRUCTURE OF HUMAN DIHYDROOROTATE DEHYDROGENASE IN COMPLEX TITLE 2 WITH THE INHIBITOR 2-HYDROXY-N-(2-ISPROPYL-5-METHYL-4-PHENOXYPHENYL) TITLE 3 PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXAMIDE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DHODEHASE,DIHYDROOROTATE OXIDASE; COMPND 5 EC: 1.3.5.2; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THE RESIDUES THAT DO NOT MATCH WITH THE INPUT SEQUENCE COMPND 8 BELONG TO THE N-TERMINAL TAG INSERTED DURING SUBCLONING PROCEDURE AND COMPND 9 THEY ARE NOT VISIBLE IN THE ELECTRON DENSITY. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DHODH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS DIHYDROOROTATE DEHYDROGENASE, INHIBITOR, COMPLEX, ACUTE MYELOID KEYWDS 2 LEUKAEMIA., OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.ALBERTI,M.L.LOLLI,D.BOSCHI,S.SAINAS,M.RIZZI,D.M.FERRARIS,R.MIGGIANO REVDAT 3 31-JAN-24 7Z6C 1 REMARK REVDAT 2 26-OCT-22 7Z6C 1 JRNL REVDAT 1 12-OCT-22 7Z6C 0 JRNL AUTH S.SAINAS,M.GIORGIS,P.CIRCOSTA,G.POLI,M.ALBERTI,A.PASSONI, JRNL AUTH 2 V.GAIDANO,A.C.PIPPIONE,N.VITALE,D.BONANNI,B.ROLANDO, JRNL AUTH 3 A.CIGNETTI,C.RAMONDETTI,A.LANNO,D.M.FERRARIS,B.CANEPA, JRNL AUTH 4 B.BUCCINNA,M.PICCININI,M.RIZZI,G.SAGLIO,S.AL-KARADAGHI, JRNL AUTH 5 D.BOSCHI,R.MIGGIANO,T.TUCCINARDI,M.L.LOLLI JRNL TITL TARGETING ACUTE MYELOGENOUS LEUKEMIA USING POTENT HUMAN JRNL TITL 2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS BASED ON THE JRNL TITL 3 2-HYDROXYPYRAZOLO[1,5- A ]PYRIDINE SCAFFOLD: SAR OF THE JRNL TITL 4 ARYLOXYARYL MOIETY. JRNL REF J.MED.CHEM. V. 65 12701 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 36162075 JRNL DOI 10.1021/ACS.JMEDCHEM.2C00496 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.55 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 51254 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.170 REMARK 3 FREE R VALUE TEST SET COUNT : 2652 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.5500 - 4.9400 0.99 2748 128 0.1942 0.1965 REMARK 3 2 4.9300 - 3.9200 1.00 2609 165 0.1619 0.1735 REMARK 3 3 3.9200 - 3.4200 1.00 2542 174 0.1590 0.1558 REMARK 3 4 3.4200 - 3.1100 1.00 2572 163 0.1651 0.1841 REMARK 3 5 3.1100 - 2.8900 1.00 2572 134 0.1709 0.1931 REMARK 3 6 2.8900 - 2.7200 1.00 2567 137 0.1791 0.1900 REMARK 3 7 2.7200 - 2.5800 1.00 2535 150 0.1741 0.2046 REMARK 3 8 2.5800 - 2.4700 1.00 2550 140 0.1748 0.1772 REMARK 3 9 2.4700 - 2.3700 1.00 2576 133 0.1727 0.1869 REMARK 3 10 2.3700 - 2.2900 1.00 2541 127 0.1748 0.2061 REMARK 3 11 2.2900 - 2.2200 1.00 2518 151 0.1692 0.2049 REMARK 3 12 2.2200 - 2.1600 1.00 2547 132 0.1795 0.1898 REMARK 3 13 2.1600 - 2.1000 1.00 2538 120 0.1906 0.2070 REMARK 3 14 2.1000 - 2.0500 1.00 2564 123 0.1881 0.2241 REMARK 3 15 2.0500 - 2.0000 1.00 2530 140 0.1856 0.2269 REMARK 3 16 2.0000 - 1.9600 1.00 2530 124 0.1972 0.2274 REMARK 3 17 1.9600 - 1.9200 1.00 2509 168 0.2100 0.2361 REMARK 3 18 1.9200 - 1.8800 1.00 2510 123 0.2389 0.2944 REMARK 3 19 1.8800 - 1.8500 0.99 2544 120 0.2442 0.2447 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.83 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7Z6C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1292121665. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JAN-22 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8731 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51366 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 48.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.11300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.76300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6OC0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE 2 M, 100 MM SODIUM REMARK 280 ACETATE PH 4.8, 30% GLYCEROL., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.68667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 41.34333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 41.34333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 82.68667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 387 O HOH A 501 1.95 REMARK 500 O HOH A 676 O HOH A 700 2.08 REMARK 500 O HOH A 633 O HOH A 674 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 31 170.74 -59.25 REMARK 500 HIS A 40 -62.29 -121.80 REMARK 500 ARG A 132 10.71 -144.44 REMARK 500 SER A 213 8.88 -152.83 REMARK 500 SER A 222 2.73 -65.93 REMARK 500 LEU A 223 46.94 -75.06 REMARK 500 TYR A 355 -61.90 -147.80 REMARK 500 REMARK 500 REMARK: NULL DBREF 7Z6C A 30 395 UNP Q02127 PYRD_HUMAN 30 395 SEQRES 1 A 366 ALA THR GLY ASP GLU ARG PHE TYR ALA GLU HIS LEU MET SEQRES 2 A 366 PRO THR LEU GLN GLY LEU LEU ASP PRO GLU SER ALA HIS SEQRES 3 A 366 ARG LEU ALA VAL ARG PHE THR SER LEU GLY LEU LEU PRO SEQRES 4 A 366 ARG ALA ARG PHE GLN ASP SER ASP MET LEU GLU VAL ARG SEQRES 5 A 366 VAL LEU GLY HIS LYS PHE ARG ASN PRO VAL GLY ILE ALA SEQRES 6 A 366 ALA GLY PHE ASP LYS HIS GLY GLU ALA VAL ASP GLY LEU SEQRES 7 A 366 TYR LYS MET GLY PHE GLY PHE VAL GLU ILE GLY SER VAL SEQRES 8 A 366 THR PRO LYS PRO GLN GLU GLY ASN PRO ARG PRO ARG VAL SEQRES 9 A 366 PHE ARG LEU PRO GLU ASP GLN ALA VAL ILE ASN ARG TYR SEQRES 10 A 366 GLY PHE ASN SER HIS GLY LEU SER VAL VAL GLU HIS ARG SEQRES 11 A 366 LEU ARG ALA ARG GLN GLN LYS GLN ALA LYS LEU THR GLU SEQRES 12 A 366 ASP GLY LEU PRO LEU GLY VAL ASN LEU GLY LYS ASN LYS SEQRES 13 A 366 THR SER VAL ASP ALA ALA GLU ASP TYR ALA GLU GLY VAL SEQRES 14 A 366 ARG VAL LEU GLY PRO LEU ALA ASP TYR LEU VAL VAL ASN SEQRES 15 A 366 VAL SER SER PRO ASN THR ALA GLY LEU ARG SER LEU GLN SEQRES 16 A 366 GLY LYS ALA GLU LEU ARG ARG LEU LEU THR LYS VAL LEU SEQRES 17 A 366 GLN GLU ARG ASP GLY LEU ARG ARG VAL HIS ARG PRO ALA SEQRES 18 A 366 VAL LEU VAL LYS ILE ALA PRO ASP LEU THR SER GLN ASP SEQRES 19 A 366 LYS GLU ASP ILE ALA SER VAL VAL LYS GLU LEU GLY ILE SEQRES 20 A 366 ASP GLY LEU ILE VAL THR ASN THR THR VAL SER ARG PRO SEQRES 21 A 366 ALA GLY LEU GLN GLY ALA LEU ARG SER GLU THR GLY GLY SEQRES 22 A 366 LEU SER GLY LYS PRO LEU ARG ASP LEU SER THR GLN THR SEQRES 23 A 366 ILE ARG GLU MET TYR ALA LEU THR GLN GLY ARG VAL PRO SEQRES 24 A 366 ILE ILE GLY VAL GLY GLY VAL SER SER GLY GLN ASP ALA SEQRES 25 A 366 LEU GLU LYS ILE ARG ALA GLY ALA SER LEU VAL GLN LEU SEQRES 26 A 366 TYR THR ALA LEU THR PHE TRP GLY PRO PRO VAL VAL GLY SEQRES 27 A 366 LYS VAL LYS ARG GLU LEU GLU ALA LEU LEU LYS GLU GLN SEQRES 28 A 366 GLY PHE GLY GLY VAL THR ASP ALA ILE GLY ALA ASP HIS SEQRES 29 A 366 ARG ARG HET FMN A 401 50 HET ORO A 402 14 HET IEQ A 403 53 HET P6G A 404 45 HET ACT A 405 7 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM ORO OROTIC ACID HETNAM IEQ ~{N}-(5-METHYL-4-PHENOXY-2-PROPAN-2-YL-PHENYL)-2- HETNAM 2 IEQ OXIDANYL-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXAMIDE HETNAM P6G HEXAETHYLENE GLYCOL HETNAM ACT ACETATE ION HETSYN FMN RIBOFLAVIN MONOPHOSPHATE HETSYN P6G POLYETHYLENE GLYCOL PEG400 FORMUL 2 FMN C17 H21 N4 O9 P FORMUL 3 ORO C5 H4 N2 O4 FORMUL 4 IEQ C24 H23 N3 O3 FORMUL 5 P6G C12 H26 O7 FORMUL 6 ACT C2 H3 O2 1- FORMUL 7 HOH *212(H2 O) HELIX 1 AA1 THR A 31 HIS A 40 1 10 HELIX 2 AA2 HIS A 40 LEU A 49 1 10 HELIX 3 AA3 ASP A 50 LEU A 64 1 15 HELIX 4 AA4 SER A 75 GLU A 79 5 5 HELIX 5 AA5 ALA A 103 MET A 110 1 8 HELIX 6 AA6 PRO A 137 ASP A 139 5 3 HELIX 7 AA7 GLY A 152 ALA A 162 1 11 HELIX 8 AA8 ARG A 163 ASP A 173 1 11 HELIX 9 AA9 ASP A 189 GLY A 202 1 14 HELIX 10 AB1 PRO A 203 ALA A 205 5 3 HELIX 11 AB2 GLY A 225 GLY A 242 1 18 HELIX 12 AB3 LEU A 243 ARG A 248 5 6 HELIX 13 AB4 THR A 260 GLY A 275 1 16 HELIX 14 AB5 LEU A 308 THR A 323 1 16 HELIX 15 AB6 SER A 337 GLY A 348 1 12 HELIX 16 AB7 TYR A 355 GLY A 362 1 8 HELIX 17 AB8 PRO A 364 GLN A 380 1 17 HELIX 18 AB9 GLY A 384 ILE A 389 1 6 HELIX 19 AC1 GLY A 390 ARG A 395 5 6 SHEET 1 AA1 2 VAL A 80 VAL A 82 0 SHEET 2 AA1 2 HIS A 85 PHE A 87 -1 O PHE A 87 N VAL A 80 SHEET 1 AA2 9 VAL A 91 ILE A 93 0 SHEET 2 AA2 9 PHE A 114 VAL A 120 1 O PHE A 114 N ILE A 93 SHEET 3 AA2 9 LEU A 177 LEU A 181 1 O GLY A 178 N VAL A 115 SHEET 4 AA2 9 TYR A 207 ASN A 211 1 O VAL A 209 N LEU A 181 SHEET 5 AA2 9 ALA A 250 ILE A 255 1 O ALA A 250 N LEU A 208 SHEET 6 AA2 9 GLY A 278 VAL A 281 1 O ILE A 280 N VAL A 253 SHEET 7 AA2 9 ILE A 329 VAL A 332 1 O ILE A 330 N VAL A 281 SHEET 8 AA2 9 LEU A 351 LEU A 354 1 O LEU A 351 N GLY A 331 SHEET 9 AA2 9 VAL A 91 ILE A 93 1 N GLY A 92 O VAL A 352 SHEET 1 AA3 3 VAL A 133 LEU A 136 0 SHEET 2 AA3 3 ALA A 141 ASN A 144 -1 O ALA A 141 N LEU A 136 SHEET 3 AA3 3 GLY A 302 GLY A 305 -1 O GLY A 302 N ASN A 144 CISPEP 1 GLY A 118 SER A 119 0 4.64 CISPEP 2 ARG A 130 PRO A 131 0 -1.22 CISPEP 3 VAL A 281 THR A 282 0 12.40 CRYST1 91.100 91.100 124.030 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010977 0.006338 0.000000 0.00000 SCALE2 0.000000 0.012675 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008063 0.00000